Matthew Biggerstaff
Biographic Data
| ID | 6062103 |
|---|---|
| NAME | Matthew Biggerstaff |
| GIVEN NAMES | Matthew |
| FAMILY NAME | Biggerstaff |
| SIGNATURE | BIGGERSTAFF M |
| AFFILIATIONS | Aaron M. Frutos, Shunte Moon, Catherine H. Bozio, Mark W. Tenforde, Matthew Biggerstaff, and Kelsey M. Sumner are with the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Alison M. Binder and Margaret A. Dudeck are with the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC. Andrea J. Cool, Kingsley Iyawe, and Trevor Thompson are with Booz Allen Hamilton, At |
| ORCID | 0000-0001-5108-8311 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 3 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
State-Level Influenza Hospitalization Burden in the United States, 2022–2023
Objectives. To develop a method leveraging hospital-based surveillance to estimate influenza-related hospitalizations by state, age, and month as a means of enhancing current US influenza burden estimation efforts. Methods. Using data from the Influenza Hospitalization Surveillance Network (FluSurv-NET), we extrapolated monthly FluSurv-NET hospitalization rates after adjusting for testing practices and diagnostic test sensitivities to non-FluSurv…
Evaluation of a Novel Data Source for National Influenza Surveillance
Objectives. To evaluate the completeness and utility of influenza hospital data reported to the Centers for Disease Control and Prevention’s National Healthcare Safety Network (NHSN) from September 2021 to April 2024. Methods. Acute care and critical access hospitals in the United States reported daily numbers of new hospital admissions of patients with laboratory-confirmed influenza to NHSN during voluntary and mandatory reporting periods. To ev…
Collaborative Hubs
Applying infectious disease forecasting to public health
These efforts, along with other infectious disease forecasting initiatives, can foster the continued advancement of forecasting science
Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017
When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical interventions (NPIs) often are the most readily available interventions to help slow transmission of the virus in communities, which is especially important before a pandemic vaccine becomes widely available. NPIs, also known as community mitigation measures, are actions that persons and communities can take to help slow the spread of respiratory virus infections, i…
Self-Reported Influenza-Like Illness and Receipt of Influenza Antiviral Drugs During the 2009 Pandemic, United States, 2009–2010
Objectives. The purpose of our study was to more accurately characterize people reporting influenza-like illness (ILI) and evaluate trends in health care seeking and influenza diagnosis and treatment during the 2009 influenza pandemic. Methods. From September 2009 to March 2010, we ascertained ILI (fever with cough or sore throat), health care seeking, and clinical diagnosis and treatment of influenza with influenza antiviral drugs among adults i…
State-Level Influenza Hospitalization Burden in the United States, 2022–2023
Objectives. To develop a method leveraging hospital-based surveillance to estimate influenza-related hospitalizations by state, age, and month as a means of enhancing current US influenza burden estimation efforts. Methods. Using data from the Influenza Hospitalization Surveillance Network (FluSurv-NET), we extrapolated monthly FluSurv-NET hospitalization rates after adjusting for testing practices and diagnostic test sensitivities to non-FluSurv…
Collaborative Hubs
Self-Reported Influenza-Like Illness and Receipt of Influenza Antiviral Drugs During the 2009 Pandemic, United States, 2009–2010
Objectives. The purpose of our study was to more accurately characterize people reporting influenza-like illness (ILI) and evaluate trends in health care seeking and influenza diagnosis and treatment during the 2009 influenza pandemic. Methods. From September 2009 to March 2010, we ascertained ILI (fever with cough or sore throat), health care seeking, and clinical diagnosis and treatment of influenza with influenza antiviral drugs among adults i…
Self-Reported Influenza-Like Illness and Receipt of Influenza Antiviral Drugs During the 2009 Pandemic, United States, 2009–2010
Objectives. The purpose of our study was to more accurately characterize people reporting influenza-like illness (ILI) and evaluate trends in health care seeking and influenza diagnosis and treatment during the 2009 influenza pandemic. Methods. From September 2009 to March 2010, we ascertained ILI (fever with cough or sore throat), health care seeking, and clinical diagnosis and treatment of influenza with influenza antiviral drugs among adults i…
Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017
When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical interventions (NPIs) often are the most readily available interventions to help slow transmission of the virus in communities, which is especially important before a pandemic vaccine becomes widely available. NPIs, also known as community mitigation measures, are actions that persons and communities can take to help slow the spread of respiratory virus infections, i…
Applying infectious disease forecasting to public health
These efforts, along with other infectious disease forecasting initiatives, can foster the continued advancement of forecasting science
Collaborative Hubs
State-Level Influenza Hospitalization Burden in the United States, 2022–2023
Objectives. To develop a method leveraging hospital-based surveillance to estimate influenza-related hospitalizations by state, age, and month as a means of enhancing current US influenza burden estimation efforts. Methods. Using data from the Influenza Hospitalization Surveillance Network (FluSurv-NET), we extrapolated monthly FluSurv-NET hospitalization rates after adjusting for testing practices and diagnostic test sensitivities to non-FluSurv…
Evaluation of a Novel Data Source for National Influenza Surveillance
Objectives. To evaluate the completeness and utility of influenza hospital data reported to the Centers for Disease Control and Prevention’s National Healthcare Safety Network (NHSN) from September 2021 to April 2024. Methods. Acute care and critical access hospitals in the United States reported daily numbers of new hospital admissions of patients with laboratory-confirmed influenza to NHSN during voluntary and mandatory reporting periods. To ev…
Influenza Virus Research Studies (6 works) · Medicine (5 works) · Data-Driven Disease Surveillance (4 works) · Environmental health (4 works) · COVID-19 epidemiological studies (3 works) · Disease (3 works) · Pandemic (3 works) · Public health (3 works) · Confidence interval (2 works) · Coronavirus disease 2019 (COVID-19) (2 works)